Overall, these findings indicate that 4-1BBL may actually enable leukemias to evade immune surveillance by inhibiting the anti-tumor activity of human NK cells through direct 4-1BB-4-1BBL interactions and by inducing release of immunosuppressive cytokines from the tumors. The gene discussed is TNFSF9; the disease is neoplasm.